Home / Opportunities / Opportunity
PROCUREMENT OPPORTUNITY

Supply and Support of Complete Antibody Quantification Testing Systems

NHS Blood and Transplant · Preliminary market engagement notice on Find a Tender

Tender information last checkedLast checked 29 Sept 2026, 23:18.

Opportunity overview

Anti-D and Anti-c Antibody Quantification NHS Blood & Transplant (NHSBT) Red Cell Immunohaematology (RCI) function is seeking to engage with suppliers of red cell antibody quantification methods via an early market engagement exercise. Please note this is not the start of a procurement process; a separate contract notice will be published to cover this requirement. Prior to commencing the formal procurement process, NHSBT would like to consult the market to improve our knowledge of all current offers available, identify further opportunities and potential issues, as well as gauge market interest in the proposed service. This engagement will help shape NHSBT procurement strategy. The RCI laboratories in NHSBT provide a range of reference services to hospitals, focusing on ensuring safe and effective blood transfusions by diagnosing and managing complex issues related to red blood cells. Antibody (anti-D and anti-c) quantification is a vital component of RCI service, predominantly providing service to NHS hospitals. The test results play a crucial role in guiding the clinical management of alloimmunised ANC patients’ by predicting the risk of haemolytic disease of the foetus and newborn and triggering referral to an FMU specialist, In addition, quantification is used to assist in the laboratory differentiation of immune anti-D from passive anti-D Ig This specialised test conducted in 4 of the 7 RCI laboratories (namely Birmingham, Colindale, Liverpool and Newcastle). RCI processes approximately 10,000 tests annually. The test is vital for identifying levels of alloimmune and prophylactic anti-D, as well as alloimmune anti-c in obstetric and other referrals. NHSBT is seeking to engage with suppliers on the market who can provide Antibody Quantification. The requirement is likely to include the following: • Quantification of anti-D and anti-c (expressed in IU/mL). • Less than 24-hour TAT • Quality requirements (such as CE marked) As part of the early market engagement exercise, NHSBT would like to discuss our requirement with suppliers along with a time frame for supply.

Classification

  • CPV33140000 — Medical consumables

Lots

  • Lot 1Value not stated

Documents and notices

Published notice details

Additional information from the published procurement release. Fields appear only when supplied by the source; check the original notice and tender documents before acting.

Scope, procedure and submissions

Id
C350958
Status
planning
Above Threshold
Yes
Main Procurement Category
goods

Legal basis

Id
2023/54
Scheme
UKPGA

Communication

Future Notice Date
3 Nov 2025, 23:59

Lots and requirements

Entry 1
Id
1
Status
planning
Has Renewal
Yes

Suitability

Sme
Yes

Contract period

Ends
11 May 2033, 23:59
Starts
11 May 2026, 00:00
Max Extent Date
11 May 2036, 23:59

Items and delivery

Item 1
Id
1
Related Lot
1

Delivery locations

Entry 1
Region
UK
Country
GB
Country Name
United Kingdom
Entry 2
Region
UKG31
Country
GB
Country Name
United Kingdom
Entry 3
Region
UKI
Country
GB
Country Name
United Kingdom
Entry 4
Region
UKK11
Country
GB
Country Name
United Kingdom

Additional Classifications

Entry 1
Id
33140000
Scheme
CPV
Description
Medical consumables

Planning and budget

Documents

Entry 1
Id
012221-2025
Format
text/html
Notice Type
UK2
Description
Preliminary market engagement notice on Find a Tender
Document Type
marketEngagementNotice
Published
1 Apr 2025, 12:31

Milestones

Entry 1
Id
engagement
Type
engagement
Status
scheduled
Due
21 May 2025, 23:59
Description
It is our intention to hold the early market engagement exercise supplier meetings the week of 19th May 2025. The meetings will be held remotely. To enable us to finalise arrangements (e.g. send meeting details and agree time slots), interested organisations are required to send an expression of interest via email to coco.otiotio@nhsbt.nhs.uk by no later than 17:00 hrs (GMT) on Friday 2nd May. This should include a list of your requested attendees and a brief overview (or a website link) of the Goods / Services which might be of interest to us in relation to this requirement. Please include options, if available, for a managed service contract. There is no guarantee that a formal procurement process will be launched as a result of this early market engagement exercise, nor that any contract(s) will be placed. No remuneration or compensation etc will be paid to organisations who take part in this early market engagement exercise. Suppliers should take part in this process only on the basis that they fully understand and accept this position.

Buyer, suppliers and contacts

Organisation 1
Id
GB-PPON-PDBY-6395-VWBP
Name
NHS Blood and Transplant

Roles

buyer

Address

Region
UKK12
Country
GB
Locality
Bristol
Postal Code
BS34 7QH
Country Name
United Kingdom
Street Address
500 North Bristol Park

Details

Classifications

Entry 1
Id
publicAuthorityCentralGovernment
Scheme
UK_CA_TYPE
Description
Public authority - central government

Identifier

Id
PDBY-6395-VWBP
Scheme
GB-PPON

Contact

Name
Coco Otiotio
Telephone
+44 7385435288

Recorded locations

  • Buyer location · Bristol · UKK12 · BS34 7QH · United Kingdom
  • Delivery location · UKG31 · United Kingdom
  • Delivery location · UKI · United Kingdom
  • Delivery location · UKK11 · United Kingdom
  • Delivery location · UK · United Kingdom

Notice and amendment history

1 published notice version reviewed by ProcuraAxis.

1 VERSION
  1. ocds-h6vhtk-04fb3d-2025-04-01T12:31:31+01:00Preliminary market engagement notice on Find a Tender ·